Skye Bioscience, Inc. — Form 4
Filed September 24, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 46/100
What the filing says
Director Schwab Andrew J. (SKYE) sold 148K shares (~$240K) on the open market (97% of holdings). Large sale — ~97% of holdings.
Why this rating
Large sale — ~97% of holdings.
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.